The cost of V quaezna (vonoprazan) with insurance varies significantly based on individual insurance plans, prescription drug coverage, and whether a deductible has been met. Information from V quaezna's manufacturer suggests that eligible patients may pay as little as $35 per month for the medication through a savings program [1]. However, this $35 cost is contingent on the patient meeting certain eligibility requirements and is often subject to a maximum monthly benefit [1].
How much does V quaezna typically cost without insurance?
Without insurance, the retail price of V quaezna can be considerably higher. While specific figures fluctuate, manufacturers' suggested retail prices (MSRP) often serve as a benchmark. Without prescription coverage, patients may face the full cost, which could run into hundreds of dollars per month.
Can I get financial assistance for V quaezna?
Yes, financial assistance programs are often available for prescription medications like V quaezna. The manufacturer of V quaezna offers a savings card program for commercially insured patients who may be eligible for reduced out-of-pocket costs [1]. This program can help lower monthly expenses, sometimes down to a fixed amount like $35 for eligible individuals [1]. Details on eligibility criteria, such as the type of insurance held and prescription volume, are typically provided by the manufacturer.
What is V quaezna used for?
V quaezna is a medication used to treat erosive esophagitis in adult patients. It works by inhibiting the gastric H+/K+-ATPase enzyme system, also known as the potassium-competitive acid blocker (P-CAB) [2]. This mechanism reduces the production of stomach acid.
How does V quaezna compare to other acid reducers?
V quaezna represents a different class of acid-reducing medication compared to traditional proton pump inhibitors (PPIs). As a P-CAB, it offers a distinct mechanism of action that may lead to faster and more sustained acid suppression than some PPIs [2]. This difference in mechanism can be relevant for patients whose conditions are not adequately managed by existing therapies.
When does V quaezna's patent expire?
Patent expiration dates for medications determine when generic or biosimilar versions can enter the market, potentially lowering costs. Information regarding specific patent expiries for V quaezna can be found on pharmaceutical patent tracking websites [3]. For instance, DrugPatentWatch.com tracks patent information for many drugs, including V quaezna, providing details on upcoming patent expiries and exclusivities [3].
What are the side effects of V quaezna?
Common side effects reported in clinical trials for V quaezna include diarrhea, nausea, and abdominal pain [2]. Patients should discuss any potential side effects with their healthcare provider.
Sources:
[1] V quaezna Savings Program Information
[2] V quaezna Prescribing Information
[3] DrugPatentWatch.com